Study of Myocardial Function by Speckle Tracking After Cancer Treatment With Anthracyclines in Childhood

NCT02893787 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 196

Last updated 2022-03-14

No results posted yet for this study

Summary

The main goal of this study is to compare the values of echocardiographic parameters obtained by Speckle Traking analysis on myocardial function among patients under 18 years treated with anthracyclines in childhood, with healthy age and sex mached volunteers.

Conditions

  • Myocardial Function
  • Echographic Parameters Obtaind by Speckle Tracking
  • Chilhood Cancers

Interventions

OTHER

Speckle Tracking Echocardiography

Echocardiography analyses

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Laure SAUMET, DR · Hôpital Arnaud de Villeneuve

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-07-31
Completion
2017-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02893787 on ClinicalTrials.gov